https://www.wellnesstodaystkittsnevis.com/article/907015146-provectus-biopharmaceuticals-to-hold-2026-annual-meeting-of-stockholders-at-perkins-place-its-planned-new-headquarters-in-knoxville-tennessee Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T22:09:00+00:00 Provectus Biopharmaceuticals to Hold 2026 Annual Meeting of Stockholders at Perkins Place, Its Planned New Headquarters in Knoxville, Tennessee https://ml.globenewswire.com/media/7cd1d796-f4d3-43f7-8e2b-eb51dc04a073/small/new-logo-png.png https://www.wellnesstodaystkittsnevis.com/article/907007985-enara-bio-presents-first-in-class-darkfox-targeting-bispecific-t-cell-engager-ena101-in-oral-presentation-at-aacr-2026-showcasing-breakthrough Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T21:30:00+00:00 Enara Bio Presents First-in-Class DARKFOX-Targeting Bispecific T Cell Engager ENA101 in Oral Presentation at AACR 2026, Showcasing Breakthrough Potential in Solid Tumor Immunotherapy https://ml-eu.globenewswire.com/media/e94da9bc-a053-4a2f-8d29-c57dba971380/small/logo-png.PNG https://www.wellnesstodaystkittsnevis.com/article/907008228-aktualisierung-bvi-gibt-bekannt-dass-virtuoso-eine-neue-chirurgische-plattform-mit-doppelfunktion-die-ce-kennzeichnung-gem-eu-mdr-erhalten Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T21:28:54+00:00 AKTUALISIERUNG -- BVI gibt bekannt, dass Virtuoso®, eine neue chirurgische Plattform mit Doppelfunktion, die CE-Kennzeichnung gemäß EU-MDR erhalten hat https://ml.globenewswire.com/media/NjNkNTUyMTQtMGZiYS00MTczLTkxNDYtN2IxMmI2YTU0ZmMyLTEyNjQwMzItMjAyNi0wNC0yMC1kZQ==/tiny/BVI-Medical-Inc-.png https://www.wellnesstodaystkittsnevis.com/article/907008243-mise-jour-bvi-annonce-l-obtention-du-marquage-ce-au-titre-du-r-glement-europ-en-sur-les-dispositifs-m-dicaux-pour-virtuoso-une-toute-nouvelle Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T21:28:54+00:00 MISE À JOUR -- BVI annonce l’obtention du marquage CE au titre du Règlement européen sur les dispositifs médicaux pour Virtuoso®, une toute nouvelle plateforme chirurgicale à double fonction https://ml.globenewswire.com/media/NjNkNTUyMTQtMGZiYS00MTczLTkxNDYtN2IxMmI2YTU0ZmMyLTEyNjQwMzItMjAyNi0wNC0yMC1mcg==/tiny/BVI-Medical-Inc-.png https://www.wellnesstodaystkittsnevis.com/article/907008038-bastiongpt-named-top-ai-platform-for-clinical-psychology-report-writing Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T21:13:00+00:00 BastionGPT Named Top AI Platform for Clinical Psychology Report Writing https://pressranger.s3.us-west-1.amazonaws.com/3234411/Top-AI-Report-Writers-Hero.jpg https://www.wellnesstodaystkittsnevis.com/article/907007986-junshi-biosciences-presents-results-from-js207-pd-1-vegf-bsab-phase-2-combo-studies-and-js212-egfr-her3-adc-fih-phase-1-2-study-at-aacr-2026 Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T21:00:00+00:00 Junshi Biosciences Presents Results from JS207 (PD-1/VEGF BsAb) Phase 2 Combo Studies and JS212 (EGFR/HER3 ADC) FIH Phase 1/2 Study at AACR 2026 https://ml.globenewswire.com/media/815f9c91-bb76-4c14-b3e9-0685275600cc/small/junshi-topalliance-logo-png.png https://www.wellnesstodaystkittsnevis.com/article/907000723-cvrx-announces-nomination-of-michael-dale-for-election-to-the-board-of-directors Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T20:30:00+00:00 CVRx Announces Nomination of Michael Dale for Election to the Board of Directors https://ml.globenewswire.com/media/04c4feba-7841-4ac8-8ca5-6c03be383a0e/small/cvrx-outsmart-the-heart-logo-rgb-blue-png.png https://www.wellnesstodaystkittsnevis.com/article/907000759-jatt-ii-acquisition-corp-announces-closing-of-60-000-000-initial-public-offering Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T20:30:00+00:00 JATT II Acquisition Corp Announces Closing of $60,000,000 Initial Public Offering https://ml.globenewswire.com/media/6124930b-cb04-4490-8614-def6ec191d09/small/1b-for-pr-jatt-2-png.png https://www.wellnesstodaystkittsnevis.com/article/907000697-spectral-ai-announces-annual-meeting-of-stockholders Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T20:15:00+00:00 Spectral AI Announces Annual Meeting of Stockholders https://ml.globenewswire.com/media/e51098e6-329d-4efc-acb5-a92a6b8f2a5d/small/spectral-ai-logo-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/907000898-si-bone-to-report-first-quarter-2026-financial-results-on-may-11-2026 Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T20:09:00+00:00 SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026 https://ml.globenewswire.com/media/1630843d-d109-4819-9c6f-455c684690ba/small/sibn-logo-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/907001325-bbot-granted-u-s-fda-fast-track-designation-for-bbo-11818-for-the-treatment-of-adult-patients-with-advanced-kras-mutant-pancreatic-ductal Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T20:06:48+00:00 BBOT Granted U.S. FDA Fast Track Designation for BBO-11818 for the Treatment of Adult Patients with Advanced KRAS-Mutant Pancreatic Ductal Adenocarcinoma https://ml.globenewswire.com/media/f5f2b913-06aa-4e1d-9368-55ff15fb3bd6/small/bbot-fullcolor-rgb-png.png https://www.wellnesstodaystkittsnevis.com/article/906998846-abivax-annual-ordinary-and-extraordinary-general-meeting-of-may-11-2026-availability-of-the-preparatory-documents Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T20:05:00+00:00 Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png https://www.wellnesstodaystkittsnevis.com/article/906998866-regeneron-announces-investor-conference-presentations Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T20:05:00+00:00 Regeneron Announces Investor Conference Presentations https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/907000274-geron-corporation-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T20:05:00+00:00 Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/e184bb51-5636-436e-8964-15613f24ca1f/small/geron-logo-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/907000281-ceribell-to-report-first-quarter-2026-financial-results-on-may-11-2026 Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T20:05:00+00:00 Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026 https://ml.globenewswire.com/media/937c5c00-41f8-45ff-b294-5f9c3f6ab2cf/small/cbll-square-logo-500x500-png.png https://www.wellnesstodaystkittsnevis.com/article/907000699-amwell-to-report-first-quarter-2026-operating-results Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T20:05:00+00:00 Amwell® to report first quarter 2026 operating results https://ml.globenewswire.com/media/ff1989f5-0a6a-4e00-99dc-cb29a818aca5/small/amwell-logo-blue-2023-v02-rgb-2-png.png https://www.wellnesstodaystkittsnevis.com/article/907000869-trevi-therapeutics-announces-closing-of-173-million-underwritten-offering-and-full-exercise-by-underwriters-of-option-to-purchase-additional-shares Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T20:05:00+00:00 Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares https://ml.globenewswire.com/media/b97e9d57-6e8e-4570-87da-ea38c273f7c8/small/trevi-logo-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/907000933-equillium-to-participate-in-oppenheimer-s-2026-innovation-on-the-island-event Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T20:05:00+00:00 Equillium to Participate in Oppenheimer’s 2026 Innovation on the Island Event https://ml.globenewswire.com/media/14ce766d-e697-461f-a27c-c1ee49c0eeff/small/equillium-logo-360x180-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/907001167-kailera-announces-closing-of-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T20:05:00+00:00 Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares https://ml.globenewswire.com/media/c0b33a3d-0c2b-45b0-ace8-6ff585b41339/small/kailera-logo-png.png https://www.wellnesstodaystkittsnevis.com/article/907000930-clearmind-medicine-welcomes-president-trump-s-executive-order-as-a-historic-catalyst-for-psychedelic-innovation-and-veteran-mental-health-care Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T20:03:00+00:00 Clearmind Medicine Welcomes President Trump’s Executive Order as a Historic Catalyst for Psychedelic Innovation and Veteran Mental Health Care https://ml.globenewswire.com/media/bd17cbf4-8124-4f86-8a4c-1fafbb6785af/small/logo-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/907000821-fibrobiologics-compliant-with-all-nasdaq-listing-requirements Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T20:01:00+00:00 FibroBiologics Compliant with All Nasdaq Listing Requirements https://ml.globenewswire.com/media/720fe0fe-52b4-4ccc-a5ad-95d4288f1df2/small/fibrobiologics-logo-2022-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/907000730-cytokinetics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T20:00:00+00:00 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://www.wellnesstodaystkittsnevis.com/article/907000929-nadp-appoints-first-dentist-to-lead-dental-informatics-program Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T20:00:00+00:00 NADP appoints first dentist to lead dental informatics program https://ml.globenewswire.com/media/4a10cf41-2ae9-4a40-a33e-49e2ed33e40f/small/nadp-logo-horizontal-2024-final-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/907000963-kfsh-se-une-al-c3-davos-of-healthcare-2026-en-sunnyvale-california-como-socio-estrat-gico-global Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T19:51:30+00:00 KFSH se une al C3 Davos of Healthcare™ 2026 en Sunnyvale, California, como socio estratégico global https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://www.wellnesstodaystkittsnevis.com/article/907000964-kfsh-participa-da-c3-davos-of-healthcare-2026-em-sunnyvale-calif-rnia-como-parceira-estrat-gica-global Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T19:51:30+00:00 KFSH Participa da C3 Davos of Healthcare™ 2026 em Sunnyvale, Califórnia, como Parceira Estratégica Global https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://www.wellnesstodaystkittsnevis.com/article/906993005-ab-science-nouvelle-publication-sur-medrxiv-d-montrant-des-b-n-fices-substantiels-en-termes-de-survie-et-de-qualit-de-vie-pr-serv-e-avec-le Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T19:32:18+00:00 AB Science : Nouvelle publication sur medrxiv démontrant des bénéfices substantiels en termes de survie et de qualité de vie préservée avec le masitinib chez les patients atteints de SLA https://ml-eu.globenewswire.com/media/90d86a0e-7ea1-47ab-99d9-69985fa76ce0/small/ https://www.wellnesstodaystkittsnevis.com/article/906993019-ab-science-new-publication-on-medrxiv-demonstrating-substantial-survival-benefits-and-preserved-quality-of-life-with-masitinib-in-als-patients Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T19:32:18+00:00 AB Science: New publication on medrxiv demonstrating substantial survival benefits and preserved quality of life with masitinib in ALS patients https://ml-eu.globenewswire.com/media/90d86a0e-7ea1-47ab-99d9-69985fa76ce0/small/logo-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906987447-flyte-emerges-as-direct-beneficiary-as-rising-fuel-costs-drive-airline-retreat-from-short-haul-routes Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T18:50:00+00:00 FLYTE EMERGES AS DIRECT BENEFICIARY AS RISING FUEL COSTS DRIVE AIRLINE RETREAT FROM SHORT-HAUL ROUTES https://ml.globenewswire.com/media/cb9f10dc-be78-4c7c-a235-81bfdd77f03c/small/catheterlogo-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906982674-lung-cancer-therapeutics-market-to-reach-49-5-billion-by-2030-driven-by-rising-cancer-incidence-and-r-d-investment-surge Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T18:19:26+00:00 Lung Cancer Therapeutics Market to Reach $49.5 Billion by 2030, Driven by Rising Cancer Incidence and R&D Investment Surge https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://www.wellnesstodaystkittsnevis.com/article/906982665-herz-p1-smart-bpm-under-investigation-clinical-grade-blood-pressure-monitoring-for-valuable-at-home-health-tracking-support Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T18:11:55+00:00 Herz P1 Smart BPM Under Investigation: Clinical-Grade Blood Pressure Monitoring for Valuable At-Home Health Tracking Support https://zingfast.com/wp-content/uploads/2026/04/Herz-P1-Smart-BPM.jpg https://www.wellnesstodaystkittsnevis.com/article/906982687-viriflow-claims-evaluated-the-prostate-supporting-formula-for-men-that-actually-works-in-viri-flow-drops-reviewed Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T18:09:54+00:00 ViriFlow Claims Evaluated: The Prostate-Supporting Formula for Men That Actually Works in Viri Flow Drops Reviewed https://zingfast.com/wp-content/uploads/2026/04/ViriFlow-1.jpg https://www.wellnesstodaystkittsnevis.com/article/906972983-lirum-therapeutics-announces-positive-lx-101-data-selected-for-presentation-at-the-2026-american-association-for-cancer-research-aacr-annual-meeting Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T17:00:00+00:00 Lirum Therapeutics Announces Positive LX-101 Data Selected for Presentation at the 2026 American Association for Cancer Research (AACR) Annual Meeting https://ml.globenewswire.com/media/09223099-97d9-4c04-8b22-ce639c0fd876/small/lirum-therapeutics-inc-logo-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906972380-stiltz-homelifts-opens-first-u-s-showroom-in-denver-showcasing-innovative-home-elevator-solutions Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T16:21:48+00:00 Stiltz Homelifts Opens First U.S. Showroom in Denver, Showcasing Innovative Home Elevator Solutions https://ml.globenewswire.com/media/NTcyZDQ0MTQtY2I4OC00NWE0LTlhZDQtZmI5MzRmODc5N2E4LTUwMDE1MTA0My0yMDI2LTA0LTIwLWVu/tiny/Stiltz-Homelifts.png https://www.wellnesstodaystkittsnevis.com/article/906967650-genfit-publication-of-the-2026-extra-financial-report-fiscal-year-2025 Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T16:00:00+00:00 GENFIT: Publication of the 2026 Extra-Financial Report (fiscal year 2025) https://ml-eu.globenewswire.com/media/NWQ4ZDk0NzEtNGJjYy00N2I0LTljZTgtNTVlNGMzMWE3NmIyLTEwMTEyNjgtMjAyNi0wNC0yMC1lbg==/tiny/GENFIT-S-A-.png https://www.wellnesstodaystkittsnevis.com/article/906967654-genfit-publication-du-rapport-de-performance-extra-financi-re-2026-exercice-2025 Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T16:00:00+00:00 GENFIT : Publication du rapport de performance extra-financière 2026 (exercice 2025) https://ml-eu.globenewswire.com/media/NWQ4ZDk0NzEtNGJjYy00N2I0LTljZTgtNTVlNGMzMWE3NmIyLTEwMTEyNjgtMjAyNi0wNC0yMC1mcg==/tiny/GENFIT-S-A-.png https://www.wellnesstodaystkittsnevis.com/article/906967984-une-analyse-m-dico-conomique-la-premi-re-du-genre-montre-que-le-recours-pr-coce-des-tests-de-diagnostic-rapides-pour-soigner-le-sepsis-pourrait Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T15:48:14+00:00 Une analyse médico-économique, la première du genre, montre que le recours précoce à des tests de diagnostic rapides pour soigner le sepsis pourrait sauver des milliers de vies au Canada et réduire les coûts du système de santé dans les pays du G… https://ml.globenewswire.com/media/a5be803c-994c-40a9-9736-fbddf2068664/small/ https://www.wellnesstodaystkittsnevis.com/article/906968109-first-of-its-kind-health-economic-analysis-shows-early-use-of-fast-diagnostics-in-sepsis-care-could-save-thousands-of-lives-in-canada-and-reduce Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T15:48:14+00:00 First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives in Canada and Reduce Health System Costs Across G7 Countries https://ml.globenewswire.com/media/a5be803c-994c-40a9-9736-fbddf2068664/small/bmx-hi-res-png-png.png https://www.wellnesstodaystkittsnevis.com/article/906967981-allsup-employment-services-highlights-tax-incentives-for-employers-hiring-through-ticket-to-work-program Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T15:45:44+00:00 Allsup Employment Services Highlights Tax Incentives For Employers Hiring Through Ticket To Work Program https://ml.globenewswire.com/media/NWExNjVhY2ItMGU4YS00MzU3LTgyNjItM2YyYWI1YjNlZTZiLTEwOTcwODEtMjAyNi0wNC0yMC1lbg==/tiny/Allsup.png https://www.wellnesstodaystkittsnevis.com/article/906967852-onward-medical-publishes-closing-of-bookbuild-offering Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T15:45:00+00:00 ONWARD Medical Publishes Closing of Bookbuild Offering https://ml.globenewswire.com/media/a60261ec-0c66-4acb-8726-e567073990a2/small/onwardresized1-png.png https://www.wellnesstodaystkittsnevis.com/article/906963267-naomi-ruth-cohen-institute-for-mental-health-education-to-host-annual-conference-addressing-the-growing-crisis-of-loneliness Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T15:15:51+00:00 Naomi Ruth Cohen Institute For Mental Health Education to Host Annual Conference Addressing the Growing Crisis of Loneliness https://ml.globenewswire.com/media/dbf190a7-e0c0-4b88-843a-d7e31bf57b45/small/the-chicago-school-logo.png https://www.wellnesstodaystkittsnevis.com/article/906958920-global-vascular-access-device-market-to-reach-usd-8-68-billion-by-2031-marketsandmarkets Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T14:30:00+00:00 Global Vascular Access Device Market to Reach USD 8.68 Billion by 2031 | MarketsandMarkets™ https://ml.globenewswire.com/media/afcc5182-4ae0-43a8-a965-4351d590b7ed/small/mnm-logo-tm-jpg-jpg.JPG https://www.wellnesstodaystkittsnevis.com/article/906954710-alayacare-and-eitan-medical-partner-to-eliminate-manual-transcription-for-home-infusion-nurses Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T14:14:14+00:00 AlayaCare and Eitan Medical partner to eliminate manual transcription for home infusion nurses https://ml.globenewswire.com/media/80920392-a416-454f-9f6c-c63983a6924e/medium/alayacare-and-eitan-medical-partner-to-eliminate-manual-tran.png https://www.wellnesstodaystkittsnevis.com/article/906954306-baba-appoints-former-mount-sinai-executive-director-to-lead-clinical-operations Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T14:00:00+00:00 Baba Appoints Former Mount Sinai Executive Director to Lead Clinical Operations https://ml.globenewswire.com/media/1152e949-0f9a-4ff0-96e1-bcdae32214aa/small/baba-logo-blue-1-png.png https://www.wellnesstodaystkittsnevis.com/article/906954500-viewsml-secures-funding-to-accelerate-commercialization-of-ai-driven-virtual-biomarker-staining-platform Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T14:00:00+00:00 ViewsML Secures Funding to Accelerate Commercialization of AI-Driven Virtual Biomarker Staining Platform https://ml.globenewswire.com/media/8484a3fc-fc06-4cd9-bcd5-2083fa5c8637/small/logo-horizontal-positive-png.png https://www.wellnesstodaystkittsnevis.com/article/906954630-bvi-announces-ce-mark-under-eu-mdr-for-virtuoso-a-brand-new-dual-function-surgical-platform Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T14:00:00+00:00 BVI Announces CE Mark Under EU MDR for Virtuoso®, A Brand New Dual-Function Surgical Platform https://ml.globenewswire.com/media/0e7f0025-cd6d-4b42-9d31-9d16f1b74c40/small/bvi-logo-png.png https://www.wellnesstodaystkittsnevis.com/article/906954618-tilray-brands-marks-4-20-reaffirming-its-leadership-in-cannabis-and-commitment-to-advancing-medical-care Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T13:56:27+00:00 Tilray Brands Marks 4/20, Reaffirming Its Leadership in Cannabis and Commitment to Advancing Medical Care https://ml.globenewswire.com/media/2dbf85bb-5e30-4623-8f9b-931442240c05/small/tilraybrands-logo-fullcolor-rbg-horiz-01-png.png https://www.wellnesstodaystkittsnevis.com/article/906950148-hinweis-zum-nichtbeachten-bvi-medical-inc Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T13:46:44+00:00 HINWEIS ZUM NICHTBEACHTEN -- BVI Medical, Inc. https://ml.globenewswire.com/media/0e7f0025-cd6d-4b42-9d31-9d16f1b74c40/small/bvi-logo-png.png https://www.wellnesstodaystkittsnevis.com/article/906950152-avis-ignorer-bvi-medical-inc Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T13:46:44+00:00 AVIS À IGNORER -- BVI Medical, Inc. https://ml.globenewswire.com/media/0e7f0025-cd6d-4b42-9d31-9d16f1b74c40/small/bvi-logo-png.png https://www.wellnesstodaystkittsnevis.com/article/906950084-3-2-bn-medical-radiation-shielding-market-forecasts-to-2034-rising-more-imaging-and-therapy-procedures-due-to-growing-chronic-diseases-and Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T13:37:26+00:00 $3.2+ BN Medical Radiation Shielding Market Forecasts to 2034: Rising More Imaging and Therapy Procedures Due to Growing Chronic Diseases and Increasing Risk Awareness https://ml.globenewswire.com/media/1f4cf0ab-7d76-4136-a6dc-a5545f80f538/small/zion-market-research-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906950102-vystar-enters-into-binding-letter-of-intent-to-acquire-50-interest-in-r3alm-inc Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T13:22:43+00:00 Vystar Enters into Binding Letter of Intent to Acquire 50% Interest in R3alm Inc. https://ml.globenewswire.com/media/08188699-078a-4d6e-ae46-c56120bb0435/small/logo-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906946311-anaptys-completes-separation-of-first-tracks-biotherapeutics-and-now-exclusively-manages-gsk-and-vanda-financial-collaborations Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T13:15:00+00:00 Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations https://ml.globenewswire.com/media/eb223f66-e7e0-4e0a-94e7-a3f7a06b13ab/small/anaptys-logo-png.png https://www.wellnesstodaystkittsnevis.com/article/906946313-first-tracks-biotherapeutics-debuts-on-nasdaq-to-advance-therapies-for-autoimmune-diseases Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T13:15:00+00:00 First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases https://ml.globenewswire.com/media/7165e7cf-d98b-4a0f-90f3-3cd8f3a6b320/small/ftb-logo-png.png https://www.wellnesstodaystkittsnevis.com/article/906946476-intelligent-bio-solutions-initiates-validation-study-for-rapid-drug-screening-cartridge-targeting-70-faster-results Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T13:15:00+00:00 Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results https://ml.globenewswire.com/media/d4eaef42-9420-48b7-8019-0285720d678c/small/ibs-primary-logo-blue-png.png https://www.wellnesstodaystkittsnevis.com/article/906945549-orion-pharma-s-odm-212-granted-orphan-drug-designation-in-mesothelioma-by-the-us-fda Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T13:00:00+00:00 Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA https://ml-eu.globenewswire.com/media/9e6a027a-eb6c-4e34-993e-b8295e6d598d/small/orionpharma-rgb-press-releases-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906945573-orion-pharman-odm-212-molekyyli-on-saanut-fda-n-harvinaisl-kestatuksen-orphan-drug-designation-mesoteliooman-hoidossa Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T13:00:00+00:00 Orion Pharman ODM-212-molekyyli on saanut FDA:n harvinaislääkestatuksen (Orphan Drug Designation) mesoteliooman hoidossa https://ml-eu.globenewswire.com/media/9e6a027a-eb6c-4e34-993e-b8295e6d598d/small/ https://www.wellnesstodaystkittsnevis.com/article/906945991-rpharmy-completes-soc-2-type-ii-audit-reinforcing-its-commitment-to-data-security-in-healthcare Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T13:00:00+00:00 Rpharmy Completes SOC 2® Type II Audit, Reinforcing Its Commitment to Data Security in Healthcare https://ml.globenewswire.com/media/d4e2107a-158e-47f0-83ff-c3ff9cca678d/small/rpharmy-charcoal-logo-png.png https://www.wellnesstodaystkittsnevis.com/article/906946091-immuneering-presents-genetic-data-at-aacr-annual-meeting-demonstrating-mechanism-to-improve-durability-and-survival-supporting-use-of-atebimetinib-in Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T13:00:00+00:00 Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond https://ml.globenewswire.com/media/81d0c83f-ae53-4d6e-9c5e-d6963e02f29d/small/immuneering-logo-cropped-1-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906946305-scilex-holding-company-announces-its-board-of-directors-approved-a-dividend-of-dream-bowl-i-meme-coin-tokens-to-holders-of-common-stock-and-other Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T13:00:00+00:00 Scilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026 https://ml.globenewswire.com/media/e2f985bf-0880-4d05-8838-90a69c888cf9/small/logo-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906946413-gh-research-welcomes-white-house-executive-order-to-accelerate-medical-treatments-for-serious-mental-illness Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T13:00:00+00:00 GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness https://ml.globenewswire.com/media/a1baa9e5-3408-4f8f-b4aa-7c4204e0971b/small/full-colour-png.png https://www.wellnesstodaystkittsnevis.com/article/906946565-oragenics-reports-8-study-drug-doses-in-phase-iia-clinical-trial-of-onp-002-for-mild-traumatic-brain-injury Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T13:00:00+00:00 Oragenics Reports 8 study drug doses in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury https://ml.globenewswire.com/media/8b2c9d06-f009-4a6e-a465-8a1fe9640993/small/logo-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906946797-avicanna-announces-agenda-for-6th-annual-clinical-symposium-on-cannabinoid-therapeutics Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T13:00:00+00:00 Avicanna Announces Agenda for 6th Annual Clinical Symposium on Cannabinoid Therapeutics https://ml.globenewswire.com/media/dff23be4-6d2a-4fbc-a561-e13c2438d17a/medium/avicanna-announces-agenda-for-6th-annual-clinical-symposium.png https://www.wellnesstodaystkittsnevis.com/article/906946773-29-6-bn-life-sciences-consulting-services-market-forecasts-to-2034-rising-drug-complexity-ai-big-data-adoption-demand-for-real-world-evidence Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:59:16+00:00 $29.6+ BN Life Sciences Consulting Services Market Forecasts to 2034: Rising Drug Complexity, AI & Big Data Adoption, Demand for Real-World Evidence, and Biotech Expansion with Novel Therapies https://ml.globenewswire.com/media/1f4cf0ab-7d76-4136-a6dc-a5545f80f538/small/zion-market-research-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906946257-omega-laboratories-to-host-educational-panels-and-present-cannabix-marijuana-breath-test-solution-at-the-2026-ndasa-conference-in-california Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:45:00+00:00 Omega Laboratories to Host Educational Panels and Present Cannabix Marijuana Breath Test Solution at the 2026 NDASA Conference in California https://ml.globenewswire.com/media/c82e010e-984e-4788-b222-2539a90d3394/small/logo-full-color-symbol-blueslash-png.png https://www.wellnesstodaystkittsnevis.com/article/906941093-akari-therapeutics-reports-positive-preclinical-data-for-aktx-101-demonstrating-differentiated-cytotoxicity-for-first-in-class-trop2-adc-payload Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:35:00+00:00 Akari Therapeutics Reports Positive Preclinical Data for AKTX-101 Demonstrating Differentiated Cytotoxicity for First-in-Class TROP2 ADC Payload Targeting RNA Splicing https://ml.globenewswire.com/media/8d978f50-07a9-40a3-be69-45f51ccd94d9/small/akari-logo-1-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906941037-integra-lifesciences-to-host-first-quarter-2026-financial-results-conference-call-on-may-5-2026 Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:32:00+00:00 Integra LifeSciences to Host First Quarter 2026 Financial Results Conference Call on May 5, 2026 https://ml.globenewswire.com/media/80d27f1a-2d8e-44f2-92e9-57e14db38652/small/integra-promotional-logos-integra-logo-full-color-process-1.png https://www.wellnesstodaystkittsnevis.com/article/906940983-allogene-therapeutics-showcases-momentum-with-clinical-and-platform-advancements-in-allogeneic-car-t-at-aacr-2026 Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:30:00+00:00 Allogene Therapeutics Showcases Momentum with Clinical and Platform Advancements in Allogeneic CAR T at AACR 2026 https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png https://www.wellnesstodaystkittsnevis.com/article/906941042-cytodyn-presents-new-leronlimab-data-in-metastatic-triple-negative-breast-cancer-at-aacr-annual-meeting-2026 Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:30:00+00:00 CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 https://ml.globenewswire.com/media/3b426b4d-6299-4c23-9f95-058174a5b7be/small/new-logo-png.png https://www.wellnesstodaystkittsnevis.com/article/906941088-envue-medical-announces-40th-u-s-hospital-customer-with-addition-of-a-virginia-medical-center-affiliated-with-the-mayo-clinic-care-network Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:30:00+00:00 ENvue Medical Announces 40th U.S. Hospital Customer with Addition of a Virginia Medical Center Affiliated with the Mayo Clinic Care Network https://ml.globenewswire.com/media/e0a97028-a7c3-4dd6-a13f-a55e43617883/small/logo-small-722-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906941213-when-science-becomes-an-asset-how-advancing-drug-pipelines-are-driving-real-time-valuation-in-biotech Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:30:00+00:00 When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech https://ml.globenewswire.com/media/920a567d-2571-4a09-a6f6-bcc7f1c26bd7/small/biomedwire-full-png.png https://www.wellnesstodaystkittsnevis.com/article/906941032-pharmala-biotech-positioned-to-supply-u-s-expanded-access-pathway-for-mdma-established-by-presidential-executive-order Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:15:00+00:00 PharmAla Biotech Positioned to Supply U.S. Expanded Access Pathway for MDMA Established by Presidential Executive Order https://ml.globenewswire.com/media/20158980-8674-43e3-a0be-a10dca42410d/small/pharmala-biotech-logo-800-x-422-png.png https://www.wellnesstodaystkittsnevis.com/article/906941539-helus-pharma-expresses-support-for-executive-order-advancing-psychedelic-research-and-regulatory-pathways-for-serious-mental-health-conditions Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:15:00+00:00 Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions https://ml.globenewswire.com/media/575a4e81-a546-4d83-a092-e8f0df765900/small/hp-pms-with-margins-png.png https://www.wellnesstodaystkittsnevis.com/article/906940974-nanox-signs-commercial-agreement-with-howard-technology-solutions-to-deploy-300-nanox-arc-systems-across-u-s-over-three-years Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:10:00+00:00 Nanox Signs Commercial Agreement with Howard Technology Solutions to Deploy 300 Nanox.ARC Systems Across U.S. Over Three Years https://ml-eu.globenewswire.com/media/7a1764f8-84e3-4b28-ae23-9add5d57c378/small/nanox-logo-4-png.png https://www.wellnesstodaystkittsnevis.com/article/906936633-boehringer-ingelheim-expands-investment-in-computational-innovation-with-new-ai-accelerator-in-uk-s-knowledge-quarter Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:00:00+00:00 Boehringer Ingelheim expands investment in computational innovation with new AI Accelerator in UK’s Knowledge Quarter https://ml-eu.globenewswire.com/media/23506caa-2f73-498b-b15b-df82c00b9b21/medium/lord-patrick-vallance-and-steve-bates-obe-with-boehringer-re.jpg https://www.wellnesstodaystkittsnevis.com/article/906936706-amneal-announces-additional-positive-interim-phase-4-elevate-pd-results-with-crexont-for-parkinson-s-disease-including-over-3-more-hours-of-daily Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:00:00+00:00 Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY® https://ml.globenewswire.com/media/a20d6f40-90af-422f-ab14-47208fdbad2f/small/amneal-rgb-k-png.png https://www.wellnesstodaystkittsnevis.com/article/906936761-fulcrum-therapeutics-to-host-first-quarter-2026-financial-results-conference-call-and-webcast-on-monday-april-27-2026-at-8-00-a-m-et Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:00:00+00:00 Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET https://ml.globenewswire.com/media/3434fc83-4bcf-4d3c-ae26-23e5b1fd4252/small/fulcrum-logo-primary-full-color-rgb-large-png.png https://www.wellnesstodaystkittsnevis.com/article/906936994-ascendis-pharma-announces-commencement-of-trading-of-its-ordinary-shares-on-nasdaq Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:00:00+00:00 Ascendis Pharma Announces Commencement of Trading of its Ordinary Shares on Nasdaq https://ml.globenewswire.com/media/b4b7c29a-478e-4a8e-b23b-b6a1cb18aee8/small/ascendis-final-logo-7-23-15-png.png https://www.wellnesstodaystkittsnevis.com/article/906937040-cosciens-biopharma-inc-provides-update-on-its-plan-to-suspend-u-s-public-company-reporting-obligations Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:00:00+00:00 COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations https://ml.globenewswire.com/media/703faafa-78e2-4d67-be2a-457eb4f57340/small/picture2-png.png https://www.wellnesstodaystkittsnevis.com/article/906937054-beyond-cancer-reports-updated-survival-and-safety-data-from-phase-1-uno-trial-presented-at-aacr-2026 Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:00:00+00:00 Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026 https://ml.globenewswire.com/media/c7ae3957-2763-4e5c-9594-57e1ba60ed59/small/beyond-air-the-magic-of-breathing-png.png https://www.wellnesstodaystkittsnevis.com/article/906937059-max-immunity-clinic-opens-in-markham-offering-regenerative-and-recovery-based-therapies Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:00:00+00:00 Max Immunity Clinic Opens in Markham, Offering Regenerative and Recovery-Based Therapies https://ml.globenewswire.com/Resource/Download/74616897-d71c-4463-8157-1c6d9219fd1a/image1.png https://www.wellnesstodaystkittsnevis.com/article/906937079-atsena-therapeutics-receives-data-monitoring-committee-recommendation-to-proceed-with-pivotal-part-c-cohort-of-phase-1-2-3-lighthouse-trial-evaluating Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:00:00+00:00 Atsena Therapeutics Receives Data Monitoring Committee Recommendation to Proceed with Pivotal Part C Cohort of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis https://ml.globenewswire.com/media/90d0bd84-4404-435c-9875-3473b4cc7172/small/atsena-logo-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906937089-kyverna-presents-longer-term-phase-2-data-for-miv-cel-in-generalized-myasthenia-gravis-at-aan-demonstrating-deep-durable-responses-through-52-weeks Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:00:00+00:00 Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks https://ml.globenewswire.com/media/c166e9f5-941a-48b0-be17-c24d54785784/small/kyverna-primary-full-2-png.png https://www.wellnesstodaystkittsnevis.com/article/906937114-tenvie-therapeutics-announces-dosing-of-first-subject-in-phase-1-clinical-trial-of-tnv108-an-allosteric-sarm1-inhibitor Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:00:00+00:00 Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV108, an Allosteric SARM1 inhibitor https://ml.globenewswire.com/media/311d9377-979c-4384-9258-5b496e854edb/small/tenvie-logo-gradient-rgb-png.png https://www.wellnesstodaystkittsnevis.com/article/906937116-bvi-gibt-bekannt-dass-virtuoso-eine-neue-chirurgische-plattform-mit-doppelfunktion-die-ce-kennzeichnung-gem-eu-mdr-erhalten-hat Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:00:00+00:00 BVI gibt bekannt, dass Virtuoso®, eine neue chirurgische Plattform mit Doppelfunktion, die CE-Kennzeichnung gemäß EU-MDR erhalten hat https://ml.globenewswire.com/media/0e7f0025-cd6d-4b42-9d31-9d16f1b74c40/small/bvi-logo-png.png https://www.wellnesstodaystkittsnevis.com/article/906937117-lenz-therapeutics-announces-submission-of-marketing-authorization-application-to-the-medicines-and-healthcare-products-regulatory-agency-for-vizz-for Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:00:00+00:00 LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdom https://ml.globenewswire.com/media/e058841a-d17f-4fd7-b817-0b2c8e6cb656/small/lenz-png.png https://www.wellnesstodaystkittsnevis.com/article/906937119-bvi-annonce-l-obtention-du-marquage-ce-au-titre-du-r-glement-europ-en-sur-les-dispositifs-m-dicaux-pour-virtuoso-une-toute-nouvelle-plateforme Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:00:00+00:00 BVI annonce l’obtention du marquage CE au titre du Règlement européen sur les dispositifs médicaux pour Virtuoso®, une toute nouvelle plateforme chirurgicale à double fonction https://ml.globenewswire.com/media/0e7f0025-cd6d-4b42-9d31-9d16f1b74c40/small/bvi-logo-png.png https://www.wellnesstodaystkittsnevis.com/article/906937121-calidi-biotherapeutics-presents-new-data-on-its-differentiated-approach-to-in-situ-t-cell-engagers-including-a-new-candidate-targeting-trop-2-at-the Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:00:00+00:00 Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026 https://ml.globenewswire.com/media/9e574b79-be62-4805-a4b4-cb0b7dcc5fbd/small/calidibiotherapeutics-logo-2x-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906937126-biocardia-and-japan-pmda-align-on-acceptability-of-cardiamp-clinical-data-to-support-regulatory-approval-in-ischemic-heart-failure Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:00:00+00:00 BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure https://ml.globenewswire.com/media/4641bb53-4913-4654-a337-79383a5c7ab9/small/biocardia-final-logo-2016-jpeg-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906937129-ardelyx-appoints-biopharmaceutical-veteran-felecia-w-ettenberg-as-chief-legal-officer Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:00:00+00:00 Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer https://ml.globenewswire.com/media/cee4ae6d-7a85-44bf-9c02-87e7fa934ec2/small/ardelyx-logo-rgb-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906937133-standard-dental-labs-inc-appoints-brendan-cummins-to-board-of-directors Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:00:00+00:00 Standard Dental Labs Inc. Appoints Brendan Cummins to Board of Directors https://ml.globenewswire.com/media/2369a47c-d78d-419f-acb4-14fafec588aa/small/sdl-logo-2023-02-png.png https://www.wellnesstodaystkittsnevis.com/article/906937134-phathom-pharmaceuticals-to-report-first-quarter-2026-financial-results-and-provide-business-update-on-thursday-april-30-2026 Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:00:00+00:00 Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026 https://ml.globenewswire.com/media/0baa6f51-c6cb-4b21-a4e0-573a18b8171c/small/phathom-pharm-logo-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906937170-nanox-announces-fourth-quarter-of-2025-financial-results-and-provides-business-updates Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:00:00+00:00 Nanox Announces Fourth Quarter of 2025 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/57c1ffd6-84b3-46b9-b9b3-76666e6ba5a2/small/nano-logo-002-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906937172-axe-compute-unveils-compute-reserve-dashboard-giving-investors-a-unified-view-of-its-nasdaq-stock-and-operational-strategic-compute-reserve Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:00:00+00:00 Axe Compute Unveils Compute Reserve Dashboard, Giving Investors a Unified View of Its NASDAQ Stock and Operational Strategic Compute Reserve https://ml.globenewswire.com/media/0722059f-4d31-435e-974f-ff669a2cb2e4/small/axe-compute.png https://www.wellnesstodaystkittsnevis.com/article/906937184-askbio-s-viralgen-to-supply-commercial-scale-drug-product-for-regenerate-pd-investigational-gene-therapy-phase-ii-trial-for-parkinson-s-disease Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:00:00+00:00 AskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease https://ml.globenewswire.com/media/MTk3Y2I1OTYtYWYwYy00MDFmLWFlNTctYTVhZjUyODU0NTNlLTEyODY3MTItMjAyNi0wNC0yMC1lbg==/tiny/Asklepios-BioPharmaceutical-In.png https://www.wellnesstodaystkittsnevis.com/article/906937392-helus-pharma-announces-chief-executive-officer-transition-eric-so-to-resume-role-as-interim-chief-executive-officer Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T12:00:00+00:00 Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer https://ml.globenewswire.com/media/575a4e81-a546-4d83-a092-e8f0df765900/small/hp-pms-with-margins-png.png https://www.wellnesstodaystkittsnevis.com/article/906937214-artelo-announces-peer-reviewed-publication-supporting-its-fabp5-inhibitor-art26-12-as-a-novel-pain-treatment-with-a-potentially-first-in-class-profile Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T11:50:00+00:00 Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile https://ml.globenewswire.com/media/460502d7-b0d3-43d8-a15a-5b2bb963bbbb/small/artelo-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906937263-psyence-biomed-positioned-as-world-s-only-licensed-pharmaceutical-grade-ibogaine-supplier-at-source Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T11:42:20+00:00 Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source https://ml.globenewswire.com/media/256a2527-4c30-46a1-a4d4-f37c89cfbff2/small/psyence-logo-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906937311-newcelx-updates-corporate-presentation-to-highlight-type-1-diabetes-flagship-program-following-strategic-collaboration-with-eledon-pharmaceuticals Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T11:37:00+00:00 NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference https://ml.globenewswire.com/media/ac801d4e-6ea5-4452-87c2-aa6a05bec73c/small/logo-positive-2x-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906931891-cronos-group-inc-to-hold-2026-first-quarter-earnings-conference-call-on-may-11-2026 Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T11:30:00+00:00 Cronos Group Inc. to Hold 2026 First Quarter Earnings Conference Call on May 11, 2026 https://ml.globenewswire.com/media/68e2d88b-b8e0-404a-995d-415a33773982/small/cronos-wm-black-logo-2-2-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906932300-palvella-therapeutics-to-present-qtorin-rapamycin-results-from-phase-3-selva-and-phase-2-toiva-studies-at-the-international-society-for-the-study-of Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T11:30:00+00:00 Palvella Therapeutics to Present QTORIN™ Rapamycin Results from Phase 3 SELVA and Phase 2 TOIVA Studies at the International Society for the Study of Vascular Anomalies World Congress 2026 https://ml.globenewswire.com/media/83fd569b-5e6c-46ad-882a-6430f8ab755a/small/palvella-2025-logo-new-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906932304-briacell-presents-positive-phase-3-quality-of-life-and-phase-2-biomarker-data-at-the-2026-aacr-meeting Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T11:30:00+00:00 BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting https://ml.globenewswire.com/media/6fd3be2a-b6a2-4f35-a39c-dfd88259d9d0/small/briacell-logo-square-a-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906932351-biogen-enters-into-agreement-with-tj-biopharma-for-felzartamab-assets-in-the-greater-china-region Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T11:30:00+00:00 Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906932744-weight-watchers-appoints-proven-healthcare-executive-heather-thiltgen-to-board-of-directors Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T11:30:00+00:00 Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors https://ml.globenewswire.com/media/f435b439-7f75-4d2f-a6cc-0e4e2ed811ea/small/weightwatchers-wordmark-boldblue-png.png https://www.wellnesstodaystkittsnevis.com/article/906932862-top-futon-mattress-2026-according-to-a-sleep-expert Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T11:28:55+00:00 Top Futon Mattress 2026: According to a Sleep Expert https://ml.globenewswire.com/media/NTliNzdmMGEtYjkxMC00MzMxLTk3MmUtMTE5NzA2YjE3ODFhLTEzMjI2ODYtMjAyNi0wNC0yMC1lbg==/tiny/Fuli-Japan-Co-Ltd.png https://www.wellnesstodaystkittsnevis.com/article/906932845-claire-s-place-foundation-s-glow-ride-returns-to-hermosa-beach-for-cf-awareness-month Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T11:18:34+00:00 Claire’s Place Foundation’s Glow Ride Returns to Hermosa Beach for CF Awareness Month https://ml.globenewswire.com/media/NWExZjVmMDYtNDkwYi00NDcxLTg2MzgtODBiOWY3NzA0NzUyLTEwOTk4OTItMjAyNi0wNC0yMC1lbg==/tiny/Claire-s-Place-Foundation.png https://www.wellnesstodaystkittsnevis.com/article/906932568-clearmind-medicine-announced-positive-top-line-safety-results-cmnd-100-proprietary-psychedelic-treatment-meets-primary-endpoint-in-aud-trial Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T11:15:00+00:00 Clearmind Medicine Announced Positive Top-Line Safety Results: CMND-100 Proprietary Psychedelic Treatment Meets Primary Endpoint in AUD Trial https://ml.globenewswire.com/media/bd17cbf4-8124-4f86-8a4c-1fafbb6785af/small/logo-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906932305-kraig-biocraft-laboratories-advances-record-production-and-begins-processing-1-8-metric-tons-of-recombinant-spider-silk-cocoons Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T11:05:00+00:00 Kraig Biocraft Laboratories Advances Record Production and Begins Processing 1.8 Metric Tons of Recombinant Spider Silk Cocoons https://ml.globenewswire.com/media/94451402-ffdd-4e78-b266-aeb3e0d7bb22/medium/jon-rice-kblbs-coo-pictured-with-less-than-4-of-the-companys.jpg https://www.wellnesstodaystkittsnevis.com/article/906932218-pasithea-therapeutics-announces-grant-of-rare-pediatric-disease-designation-rpdd-by-fda-to-pas-004-for-treatment-of-neurofibromatosis-type-1-nf1 Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T11:01:00+00:00 Pasithea Therapeutics Announces Grant of Rare Pediatric Disease Designation (RPDD) by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) https://ml.globenewswire.com/media/0016f128-13c3-45a7-8455-cec1f4768995/small/pasithealogo-png.png https://www.wellnesstodaystkittsnevis.com/article/906932225-invivyd-announces-chairman-marc-elia-to-speak-at-politico-health-care-summit Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T11:01:00+00:00 Invivyd Announces Chairman Marc Elia to Speak at POLITICO Health Care Summit https://ml.globenewswire.com/media/7bf12f50-1073-4ce7-81ac-89426c07add3/small/untitled-design-2-png.png https://www.wellnesstodaystkittsnevis.com/article/906931864-radiopharm-theranostics-presents-initial-findings-from-phase-1-first-in-human-heat-clinical-trial-for-177lu-rad202-in-her2-solid-tumors-at-american Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T11:00:00+00:00 Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026 https://ml-eu.globenewswire.com/media/8e246920-183e-46a4-b13c-a3c9ec50ada9/small/radx-logo-png.png https://www.wellnesstodaystkittsnevis.com/article/906931872-sagimet-biosciences-announces-appointment-of-andreas-grauer-md-as-chief-medical-officer Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T11:00:00+00:00 Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer https://ml.globenewswire.com/media/e944daed-3f71-402b-bb23-82149e5c0d26/small/sagimet-logo-for-light-bg-fin-png.png https://www.wellnesstodaystkittsnevis.com/article/906931895-soleo-health-expands-rare-disease-capabilities-with-launch-of-soleorare-a-specialty-pharmacy-focused-on-complex-patient-needs Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T11:00:00+00:00 Soleo Health Expands Rare Disease Capabilities With Launch of SoleoRare™, A Specialty Pharmacy Focused on Complex Patient Needs https://ml.globenewswire.com/media/b3c4bcdc-fa25-4f50-8b81-09f13e80a008/small/soleo-logo-1024-x-1024-png.png https://www.wellnesstodaystkittsnevis.com/article/906931981-seres-therapeutics-showcases-ser-155-data-and-live-biotherapeutic-insights-at-escmid-global-2026 Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T11:00:00+00:00 Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026 https://ml.globenewswire.com/media/f8c3ad50-d1a3-457d-b0c7-8f9237db7f93/small/seres-logo-png.png https://www.wellnesstodaystkittsnevis.com/article/906932066-passage-bio-reports-updated-interim-data-from-uplift-d-trial-and-provides-regulatory-and-corporate-updates Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T11:00:00+00:00 Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates https://ml.globenewswire.com/media/b5b65eab-3831-4f38-a1e8-b9f8d9f028d7/small/logo-1-jpg.JPG https://www.wellnesstodaystkittsnevis.com/article/906932228-netramark-comments-on-u-s-executive-order-to-accelerate-treatments-for-serious-mental-illness-and-highlights-the-need-for-regulatory-grade-trial Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T11:00:00+00:00 Netramark Comments on U.S. Executive Order to Accelerate Treatments for Serious Mental Illness and Highlights the Need for Regulatory‑Grade Trial Design in Psychedelic Development https://ml.globenewswire.com/media/d65cf3f8-cf9c-475c-b740-09a659269da4/small/netramark-word-eye-blk-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906932245-monte-rosa-therapeutics-presents-preclinical-data-at-american-association-for-cancer-research-aacr-annual-meeting-2026-on-the-potential-of-its Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T11:00:00+00:00 Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2026 on the Potential of its Cyclin E1 (CCNE1)-directed Molecular Glue Degrader to Treat CCNE1-amplified Solid Tumors https://ml.globenewswire.com/media/20ed9999-454a-4e2a-aabc-217270a87d2d/small/mrtx-logo-primaryblue-4cp-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906932307-nrx-pharmaceuticals-nasdaq-nrxp-welcomes-presidential-initiative-to-accelerate-approval-of-psychedelic-medications-to-treat-depression-ptsd-and Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T11:00:00+00:00 NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality https://ml.globenewswire.com/media/d879f1ff-d5d7-48d7-9731-c881b469d873/small/nrx-logo-300dpi-png.png https://www.wellnesstodaystkittsnevis.com/article/906932314-conavi-medical-announces-fda-510-k-clearance-of-its-next-generation-hybrid-ivus-oct-system-for-intravascular-imaging Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T11:00:00+00:00 Conavi Medical Announces FDA 510(k) Clearance of its Next-Generation Hybrid IVUS-OCT System for Intravascular Imaging https://ml.globenewswire.com/media/4a28f1c0-f99d-4940-b2a7-201ab98cdaff/small/conavi-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906932319-seres-therapeutics-showcases-ser-155-data-and-live-biotherapeutic-insights-at-escmid-global-2026 Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T11:00:00+00:00 Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026 https://ml.globenewswire.com/media/f8c3ad50-d1a3-457d-b0c7-8f9237db7f93/small/seres-logo-png.png https://www.wellnesstodaystkittsnevis.com/article/906927423-ani-pharmaceuticals-announces-the-fda-approval-and-launch-of-pimozide-tablets-with-180-day-cgt-exclusivity Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T10:50:00+00:00 ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity https://ml.globenewswire.com/media/24d1d851-9075-4d6e-b22c-0c23a5ef0b36/small/ani-logo-png.png https://www.wellnesstodaystkittsnevis.com/article/906927583-evidence-supporting-combined-use-of-deucrictibant-ir-with-deucrictibant-xr-presented-at-ciic-spring-2026-conference Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T10:50:00+00:00 Evidence Supporting Combined Use of Deucrictibant IR with Deucrictibant XR Presented at CIIC Spring 2026 Conference https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png https://www.wellnesstodaystkittsnevis.com/article/906927640-silo-pharma-positioned-to-advance-treatment-targeting-ptsd-as-president-trump-signs-executive-order-aimed-at-accelerating-research-and-treatment-based Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T10:34:00+00:00 Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics https://ml.globenewswire.com/media/3b635464-4382-4b8b-8175-39cc32e08050/small/logo-png.png https://www.wellnesstodaystkittsnevis.com/article/906927646-prelude-therapeutics-announces-pricing-of-90-0-million-underwritten-offering Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T10:30:00+00:00 Prelude Therapeutics Announces Pricing of $90.0 Million Underwritten Offering https://ml.globenewswire.com/media/cab62748-b61a-42cb-b552-b0c6c91c4e83/small/ptx-logo-png.png https://www.wellnesstodaystkittsnevis.com/article/906922925-kfsh-joins-c3-davos-of-healthcare-2026-in-sunnyvale-california-as-a-global-strategic-partner Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T10:12:35+00:00 KFSH Joins C3 Davos of Healthcare™ 2026 in Sunnyvale, California, as a Global Strategic Partner https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://www.wellnesstodaystkittsnevis.com/article/906922856-biodesix-to-report-first-quarter-2026-financial-results-on-may-4-2026 Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T10:00:00+00:00 Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026 https://ml.globenewswire.com/media/b2fd8e3c-ff04-47d9-938d-93c9c961ccc3/small/bdsx-logo-1200x240-png.png https://www.wellnesstodaystkittsnevis.com/article/906922873-prelude-therapeutics-presents-preclinical-data-from-development-candidate-prt13722-a-first-in-class-orally-bioavailable-potent-and-highly Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T10:00:00+00:00 Prelude Therapeutics Presents Preclinical Data from Development Candidate, PRT13722, a First-in-Class, Orally Bioavailable, Potent and Highly Selective KAT6A Degrader at American Association for Cancer Research (AACR) Annual Meeting 2026 https://ml.globenewswire.com/media/cab62748-b61a-42cb-b552-b0c6c91c4e83/small/ptx-logo-png.png https://www.wellnesstodaystkittsnevis.com/article/906922975-greenwich-lifesciences-presents-flamingo-01-phase-iii-trial-open-label-data-published-at-aacr-meeting-2026 Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T10:00:00+00:00 Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026 https://ml.globenewswire.com/media/e0bfd967-b05f-43d2-91b4-d2a5d551df99/small/logo-edited-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906909326-oculis-announces-completion-of-last-patient-visit-in-phase-3-diamond-program-with-ocs-01-eye-drops-for-the-treatment-of-diabetic-macular-edema Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T08:00:00+00:00 Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema https://ml-eu.globenewswire.com/media/f6fa6e90-83a4-4baa-a3b6-5483017d26b9/small/oculis-logo-gradient-jpg-resized-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906895910-nxera-pharma-to-receive-us-10-million-milestone-payment-from-abbvie-under-collaboration-targeting-neurological-diseases Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T06:30:00+00:00 Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases https://ml-eu.globenewswire.com/media/5cc74d52-c86f-4e21-8684-3496281fee15/small/nxera-master-logo-rgb-black-1-png.png https://www.wellnesstodaystkittsnevis.com/article/906895935-nanobiotix-annonce-de-nouvelles-donn-es-pr-cliniques-d-montrant-une-am-lioration-de-la-biodisponibilit-syst-mique-et-la-r-duction-de-la-toxicit-pour Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T06:30:00+00:00 Nanobiotix annonce de nouvelles données précliniques démontrant une amélioration de la biodisponibilité systémique et la réduction de la toxicité pour des immunothérapies à ADN delivrées par LNP après traitement avec sa technologie de… https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906896055-nanobiotix-announces-new-preclinical-data-supporting-improved-systemic-bioavailability-and-reduced-toxicity-for-lnp-delivered-dna-immunotherapy-after Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T06:30:00+00:00 Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906891437-reminder-last-exercise-day-for-nicox-june-2024-warrants-is-june-19-2026 Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T05:30:00+00:00 Reminder: Last Exercise Day for Nicox June 2024 Warrants is June 19, 2026 https://ml-eu.globenewswire.com/media/c4c68e53-e467-4048-b580-d1596c4d6d8e/small/logo-png.png https://www.wellnesstodaystkittsnevis.com/article/906891441-rappel-le-dernier-jour-d-exercice-pour-les-bons-de-souscription-d-actions-bsa-nicox-de-juin-2024-est-le-19-juin-2026 Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T05:30:00+00:00 Rappel : le dernier jour d’exercice pour les Bons de Souscription d’Actions (BSA) Nicox de juin 2024 est le 19 juin 2026 https://ml-eu.globenewswire.com/media/c4c68e53-e467-4048-b580-d1596c4d6d8e/small/ https://www.wellnesstodaystkittsnevis.com/article/906845683-ascentage-pharma-to-present-four-promising-preclinical-studies-demonstrating-the-potential-of-combination-therapies-at-american-association-for-cancer Wellness Today St. Kitts & Nevis en PressRelease 2026-04-20T00:00:00+00:00 Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meeting https://ml.globenewswire.com/media/b9623a51-a13b-4b80-8152-61d5014f4a0a/small/2025-11-12-ascentage-600x600-png.png https://www.wellnesstodaystkittsnevis.com/article/906845652-sutro-biopharma-presents-promising-preclinical-data-across-its-pipeline-of-next-generation-single-and-dual-payload-adc-programs-at-aacr-2026 Wellness Today St. Kitts & Nevis en PressRelease 2026-04-19T23:45:00+00:00 Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026 https://ml.globenewswire.com/media/b29d64ff-a5d8-41ff-9d46-e0e332cc7f28/small/image001-png.png https://www.wellnesstodaystkittsnevis.com/article/906841121-monopar-presents-phase-3-data-showing-greater-neurologic-benefit-with-alxn1840-vs-soc-in-wilson-disease-patients-with-neurologic-symptoms-at-aan-2026 Wellness Today St. Kitts & Nevis en PressRelease 2026-04-19T23:00:00+00:00 Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit with ALXN1840 vs SoC in Wilson Disease Patients with Neurologic Symptoms at AAN 2026 https://ml.globenewswire.com/media/f8cee181-5ae9-4a02-84f5-6e35affbb72b/small/monopartherapeuticsinc-png.png https://www.wellnesstodaystkittsnevis.com/article/906832668-kimmtrak-doubles-the-likelihood-of-being-alive-at-five-years-for-first-line-hla-a-02-01-patients-with-metastatic-uveal-melanoma Wellness Today St. Kitts & Nevis en PressRelease 2026-04-19T22:00:00+00:00 KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma https://ml-eu.globenewswire.com/media/bcaafaab-2536-4b4b-899c-9913925b6e4b/small/immunocore-logo-2018.png https://www.wellnesstodaystkittsnevis.com/article/906832675-xenon-presents-azetukalner-phase-3-x-tole2-study-results-and-48-month-long-term-data-in-focal-onset-seizures-at-2026-aan-annual-meeting Wellness Today St. Kitts & Nevis en PressRelease 2026-04-19T22:00:00+00:00 Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting https://ml.globenewswire.com/media/505b89d3-dfd1-46e8-bc3b-3c9c699ef7ec/small/xenon-logo-tm-full-color-250x80px-png.png https://www.wellnesstodaystkittsnevis.com/article/906816139-transactions-in-zealand-pharma-shares-and-or-related-securities-by-persons-discharging-managerial-responsibilities-and-or-their-closely-associated Wellness Today St. Kitts & Nevis en PressRelease 2026-04-19T20:05:00+00:00 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons https://ml-eu.globenewswire.com/media/31b5d115-c4a3-4dfd-b20e-d222199c4862/small/zealand-logo-1-png.png https://www.wellnesstodaystkittsnevis.com/article/906816100-zealand-pharma-launches-long-term-incentive-programs-for-zealand-pharma-s-board-of-directors-corporate-management-and-employees-for-2026 Wellness Today St. Kitts & Nevis en PressRelease 2026-04-19T20:00:00+00:00 Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2026 https://ml-eu.globenewswire.com/media/31b5d115-c4a3-4dfd-b20e-d222199c4862/small/zealand-logo-1-png.png https://www.wellnesstodaystkittsnevis.com/article/906800541-revolution-medicines-to-present-updated-phase-1-clinical-data-for-zoldonrasib-in-patients-with-previously-treated-kras-g12d-non-small-cell-lung-cancer Wellness Today St. Kitts & Nevis en PressRelease 2026-04-19T18:00:00+00:00 Revolution Medicines to Present Updated Phase 1 Clinical Data for Zoldonrasib in Patients with Previously Treated KRAS G12D Non-Small Cell Lung Cancer at the 2026 AACR Annual Meeting https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png https://www.wellnesstodaystkittsnevis.com/article/906786185-molecular-partners-presents-three-posters-at-aacr-2026-with-new-preclinical-data-for-first-switch-darpin-t-cell-engager-mp0632-and-dll3-radio-darpin Wellness Today St. Kitts & Nevis en PressRelease 2026-04-19T16:00:00+00:00 Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712 https://ml.globenewswire.com/media/ac0d728a-e43a-4d2b-a9c5-52e74d0dd1eb/small/molecularpartners-logo-jpg.jpg https://www.wellnesstodaystkittsnevis.com/article/906641487-herz-p1-smart-oximeter-claims-evaluated-best-pulse-oxygen-monitor-device-on-the-market-with-clinical-grade-accuracy Wellness Today St. Kitts & Nevis en PressRelease 2026-04-18T23:25:01+00:00 Herz P1 Smart Oximeter Claims Evaluated: Best Pulse Oxygen Monitor Device on the Market with Clinical-Grade Accuracy https://zingfast.com/wp-content/uploads/2026/04/Herz-P1-Smart-Oximeter.jpg